Levofloxacine Viatris

Levofloxacin, the active ingredient in Levofloxacine Viatris, is a fluoroquinolone antibiotic presented as an oral tablet for systemic use. It treats a range of bacterial infections, including urinary tract, respiratory, skin, and intra‑abdominal infections, in adult patients. GNH USA supplies Levofloxacine Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacine Viatris is a fluoroquinolone antibiotic indicated for several bacterial infection categories. - Urinary tract infections: eradicates susceptible Gram‑negative and Gram‑positive pathogens causing uncomplicated and complicated UTIs. - Community‑acquired respiratory tract infections: treats pneumonia, bronchitis and other lower respiratory infections caused by susceptible organisms. - Skin and soft‑tissue infections: effective against cellulitis, abscesses and wound infections due to susceptible bacteria. - Acute bacterial prostatitis: resolves infection of the prostate gland caused by levofloxacin‑sensitive strains. - Complicated intra‑abdominal infections: used as part of combination therapy for polymicrobial intra‑abdominal infections.

Levofloxacine Viatris may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: anaphylaxis, angioedema, or Stevens‑Johnson syndrome. - Clostridioides difficile infection: severe colitis following disruption of gut flora. - Peripheral neuropathy: numbness or tingling in extremities. - Hepatic dysfunction: elevated liver enzymes or hepatitis.

Levofloxacine Viatris requires careful patient assessment before use. - Renal function assessment: adjust dose in patients with impaired clearance. - Tendon disorder avoidance: do not use in patients with a history of tendon disease or recent corticosteroid therapy. - Cardiac monitoring: avoid in individuals with known QT prolongation or electrolyte disturbances. - Hypersensitivity vigilance: discontinue if signs of severe allergic reaction appear. - Pregnancy and lactation: use only if benefits outweigh potential risks, after professional consultation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Levofloxacine Viatris can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Concomitant fluoroquinolones: additive toxicity. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased risk of CNS stimulation. - Antacids containing magnesium or aluminum: reduced levofloxacin absorption. - Warfarin: enhanced anticoagulant effect, monitor INR closely. - Cyclosporine: elevated cyclosporine serum concentrations.

Moderate Interactions (Monitor Closely): - Oral hypoglycemic agents: potential for hypoglycemia. - Theophylline: increased plasma levels, risk of toxicity. - Corticosteroids: heightened risk of tendon rupture. - Sulfonylureas: possible enhanced glucose‑lowering effect. - Oral contraceptives: reduced hormonal efficacy, consider backup contraception.